DE69719191D1 - Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren - Google Patents
Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptorenInfo
- Publication number
- DE69719191D1 DE69719191D1 DE69719191T DE69719191T DE69719191D1 DE 69719191 D1 DE69719191 D1 DE 69719191D1 DE 69719191 T DE69719191 T DE 69719191T DE 69719191 T DE69719191 T DE 69719191T DE 69719191 D1 DE69719191 D1 DE 69719191D1
- Authority
- DE
- Germany
- Prior art keywords
- dopamine
- modulators
- receptors
- tetrahydroisoquinoline derivatives
- tetrahydroisoquinoline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000004073 Dopamine D3 Receptors Human genes 0.000 title 1
- 108090000525 Dopamine D3 Receptors Proteins 0.000 title 1
- 150000003526 tetrahydroisoquinolines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9609888.4A GB9609888D0 (en) | 1996-05-11 | 1996-05-11 | Compounds |
| GBGB9617189.7A GB9617189D0 (en) | 1996-08-16 | 1996-08-16 | Compounds |
| GBGB9704490.3A GB9704490D0 (en) | 1997-03-05 | 1997-03-05 | Compounds |
| PCT/EP1997/002434 WO1997043262A1 (en) | 1996-05-11 | 1997-05-06 | Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69719191D1 true DE69719191D1 (de) | 2003-03-27 |
| DE69719191T2 DE69719191T2 (de) | 2003-11-27 |
Family
ID=27268278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69719191T Expired - Fee Related DE69719191T2 (de) | 1996-05-11 | 1997-05-06 | Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6046210A (de) |
| EP (1) | EP0917530B1 (de) |
| JP (1) | JP2000510137A (de) |
| KR (1) | KR20000010905A (de) |
| AR (1) | AR007077A1 (de) |
| AT (1) | ATE232850T1 (de) |
| AU (1) | AU2897497A (de) |
| BR (1) | BR9709220A (de) |
| CA (1) | CA2253927A1 (de) |
| CZ (1) | CZ363298A3 (de) |
| DE (1) | DE69719191T2 (de) |
| ES (1) | ES2191838T3 (de) |
| IL (1) | IL126747A0 (de) |
| NO (1) | NO985242L (de) |
| NZ (1) | NZ332477A (de) |
| PL (1) | PL329803A1 (de) |
| TR (1) | TR199802284T2 (de) |
| WO (1) | WO1997043262A1 (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4204697A (en) * | 1996-08-14 | 1998-03-06 | Smithkline Beecham Plc | Tetrahydroisoquinoline derivatives and their pharmaceutical use |
| GB9708694D0 (en) * | 1997-04-30 | 1997-06-18 | Smithkline Beecham Plc | Compounds |
| GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| PL336628A1 (en) * | 1997-05-03 | 2000-07-03 | Smithkline Beecham Plc | Derivatives of tetrahydroisoquinoline as modulators of d3 dopamine receptors |
| GB9709303D0 (en) * | 1997-05-09 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
| TW450954B (en) * | 1998-05-14 | 2001-08-21 | Pharmacia & Amp Upjohn Company | Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| GB9810876D0 (en) | 1998-05-20 | 1998-07-22 | Smithkline Beecham Plc | Compounds |
| GB9812522D0 (en) * | 1998-06-10 | 1998-08-05 | Smithkline Beecham Plc | Compounds |
| GB9821978D0 (en) | 1998-10-08 | 1998-12-02 | Smithkline Beecham Plc | Compounds |
| DE69929704T2 (de) * | 1998-10-08 | 2006-07-20 | Smithkline Beecham Plc, Brentford | Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel) |
| GB9821977D0 (en) * | 1998-10-08 | 1998-12-02 | Smithkline Beecham Plc | Compounds |
| AR022229A1 (es) * | 1999-01-12 | 2002-09-04 | Abbott Gmbh & Co Kg | Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion |
| TW200403223A (en) | 2002-02-15 | 2004-03-01 | Glaxo Group Ltd | Novel compounds |
| TWI281914B (en) | 2002-05-29 | 2007-06-01 | Glaxo Group Ltd | Compounds |
| WO2005048810A2 (en) * | 2003-07-31 | 2005-06-02 | Washington University In St. Louis | Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| US7659400B2 (en) * | 2003-07-31 | 2010-02-09 | Washington University | Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| MX2007000669A (es) * | 2004-07-20 | 2007-05-23 | Siena Biotech Spa | Moduladores de receptores acetilcolina nicotinicos alfa 7 y sus usos terapeuticos. |
| WO2006113261A2 (en) * | 2005-04-14 | 2006-10-26 | Bristol-Myers Squibb Company | Inhibitors of 11-beta hydroxysteroid dehydrogenase type i |
| CL2008000119A1 (es) | 2007-01-16 | 2008-05-16 | Wyeth Corp | Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia. |
| US9227944B2 (en) | 2008-10-10 | 2016-01-05 | Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China | Dopamine D3 receptor ligands and preparation and medical uses of the same |
| EP2354136B1 (de) | 2008-10-10 | 2016-02-24 | Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. China | Neue dopamin-d3-rezeptorliganden, ihre herstellung und verwendung |
| WO2016034671A1 (en) | 2014-09-03 | 2016-03-10 | Ctxt Pty Ltd | Aminoindane-, aminotetrahydronaphthalene- and aminobenzocyclobutane-derived prmt5-inhibitors |
| GB201415573D0 (en) | 2014-09-03 | 2014-10-15 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| WO2016034673A1 (en) | 2014-09-03 | 2016-03-10 | Ctxt Pty Ltd | Tetrahydroisoquinoline derived prmt5-inhibitors |
| GB201604029D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604027D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604022D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604031D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604020D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| GB201604030D0 (en) | 2016-03-09 | 2016-04-20 | Ctxt Pty Ltd | Compounds |
| EP3495363B1 (de) | 2016-07-28 | 2023-08-23 | Shionogi & Co., Ltd | Stickstoffhaltige kondensierte ringverbindungen mit antagonistischer dopamin-d3-rezeptor-wirkung |
| TW201938537A (zh) | 2018-01-26 | 2019-10-01 | 日商鹽野義製藥股份有限公司 | 具有多巴胺ｄ３受體拮抗作用的稠環化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5294621A (en) * | 1992-10-07 | 1994-03-15 | Ortho Pharmaceutical Corporation | Thieno tetrahydropyridines useful as class III antiarrhythmic agents |
| DE4425146A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
-
1997
- 1997-05-06 CA CA002253927A patent/CA2253927A1/en not_active Abandoned
- 1997-05-06 KR KR1019980709052A patent/KR20000010905A/ko not_active Application Discontinuation
- 1997-05-06 JP JP09540515A patent/JP2000510137A/ja not_active Ceased
- 1997-05-06 DE DE69719191T patent/DE69719191T2/de not_active Expired - Fee Related
- 1997-05-06 US US09/180,156 patent/US6046210A/en not_active Expired - Fee Related
- 1997-05-06 ES ES97923065T patent/ES2191838T3/es not_active Expired - Lifetime
- 1997-05-06 BR BR9709220A patent/BR9709220A/pt not_active Application Discontinuation
- 1997-05-06 EP EP97923065A patent/EP0917530B1/de not_active Expired - Lifetime
- 1997-05-06 WO PCT/EP1997/002434 patent/WO1997043262A1/en not_active Application Discontinuation
- 1997-05-06 CZ CZ983632A patent/CZ363298A3/cs unknown
- 1997-05-06 AU AU28974/97A patent/AU2897497A/en not_active Abandoned
- 1997-05-06 IL IL12674797A patent/IL126747A0/xx unknown
- 1997-05-06 AT AT97923065T patent/ATE232850T1/de not_active IP Right Cessation
- 1997-05-06 PL PL97329803A patent/PL329803A1/xx unknown
- 1997-05-06 NZ NZ332477A patent/NZ332477A/xx unknown
- 1997-05-06 TR TR1998/02284T patent/TR199802284T2/xx unknown
- 1997-05-09 AR ARP970101953A patent/AR007077A1/es unknown
-
1998
- 1998-11-10 NO NO985242A patent/NO985242L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69719191T2 (de) | 2003-11-27 |
| TR199802284T2 (xx) | 2000-05-22 |
| PL329803A1 (en) | 1999-04-12 |
| KR20000010905A (ko) | 2000-02-25 |
| WO1997043262A1 (en) | 1997-11-20 |
| AR007077A1 (es) | 1999-10-13 |
| CZ363298A3 (cs) | 1999-06-16 |
| EP0917530B1 (de) | 2003-02-19 |
| NO985242D0 (no) | 1998-11-10 |
| ATE232850T1 (de) | 2003-03-15 |
| JP2000510137A (ja) | 2000-08-08 |
| IL126747A0 (en) | 1999-08-17 |
| BR9709220A (pt) | 1999-08-10 |
| ES2191838T3 (es) | 2003-09-16 |
| US6046210A (en) | 2000-04-04 |
| AU2897497A (en) | 1997-12-05 |
| CA2253927A1 (en) | 1997-11-20 |
| NZ332477A (en) | 2000-07-28 |
| EP0917530A1 (de) | 1999-05-26 |
| NO985242L (no) | 1998-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69719191D1 (de) | Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren | |
| DE69605430D1 (de) | Chinolin-2-on derivate als serotonin antagonisten | |
| NO995338D0 (no) | Tetrahydroisokinolinderivater som modulatorer for dopamin-D3-reseptorer | |
| DE69813616D1 (de) | Cyclohexencarboxylate als inhibitoren der neuraminidase | |
| DE69712331D1 (de) | Pyrimidin-4-on derivate als pestizidesmittel | |
| DE69628334D1 (de) | Chinolin derivate als nk3 antagoniste | |
| ATE149163T1 (de) | Indolin derivate als 5ht2c antagonisten | |
| DE69723446D1 (de) | Oxindole derivate | |
| PT1001934E (pt) | Compostos de indole como inibidores de cox-2 | |
| ATE229940T1 (de) | 3-spiro-indolin-2-onderivate als liganden der vasopressin und/oder der ocytocin rezeptoren | |
| DE69841138D1 (de) | Imidazolderivate als mdr-modulatoren | |
| ATE221052T1 (de) | Tetrahydrochinolinderivate als eaa antagonisten | |
| PT1036072E (pt) | Antagonistas de receptores de trombina | |
| DE69819903D1 (de) | Bizyklische verbindungen als liganden der 5-ht1 rezeptoren | |
| PT696194E (pt) | Utilizacao de derivados de indole como antagonistas de 5ht1 | |
| ATE254621T1 (de) | Thienoisoxazolyl- und thienylpyrazolyl-phenoxy substituierte propyl derivate als d4 antagonisten | |
| DE69703242D1 (de) | Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten | |
| DE69735811D1 (de) | Piperazinoderivate als neurokinin-antagonisten | |
| ATE212631T1 (de) | 8-azabicyclo(3.2.1)0ctan-3-methanaminderivate als liganden der dopamin-rezeptoren d2 und d3 und der serotonin-rezeptoren 5ht1a und 5ht2 | |
| EE9800281A (et) | Kondenseeritud imidasoolderivaadid multiravimiresistentsi moduleerijatena | |
| ATE219051T1 (de) | 5-aroylnaphthalin derivate | |
| DE69717449D1 (de) | Indolin-derivate verwendbar als 5-ht-2c rezeptor-antagonisten | |
| DE69903627D1 (de) | Tetrahydroisochinolinderivate als modulatoren von dopamin d3 rezeptoren | |
| DE69617010D1 (de) | Isazole derivate als fibrinogen-rezeptor-antagonisten | |
| ATE305925T1 (de) | Positive modulatoren von nicotinrezeptor- agonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8339 | Ceased/non-payment of the annual fee |